John B. Bode, Director at ZEVRA THERAPEUTICS, INC. (ZVRA), bought 10,000 shares at $5.04 ($50K) on 2023-05-18, disclosed to the SEC on 2023-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.04 | 300 | $2K | 3.0% |
| 2 | $5.04 | 1,000 | $5K | 10.0% |
| 3 | $5.04 | 1,390 | $7K | 13.9% |
| 4 | $5.04 | 4,759 | $24K | 47.6% |
| 5 | $5.05 | 100 | $505 | 1.0% |
| 6 | $5.05 | 2,451 |
| $12K |
| 24.5% |
| Total | $5.04 avg | 10,000 | $50K | 100% |
| Filing → |
| ZVRA | BUY | 2024-07-15 | $59K | — | Filing → |
| ZVRA | BUY | 2023-09-06 | $51K | — | Filing → |
| TPUB | BUY | 2014-11-12 | $51K | — | Filing → |